Company Overview of Calixa Therapeutics, Inc.
Calixa Therapeutics, Inc., a biopharmaceutical company, focuses on the development of novel antibiotics that address the problem of multi drug resistant gram negative pathogens. The company was founded in 2007 and is based in San Diego, California. As of December 16, 2009, Calixa Therapeutics, Inc. operates as a subsidiary of Cubist Pharmaceuticals Inc.
12481 High Bluff Drive
San Diego, CA 92130
Founded in 2007
Key Executives for Calixa Therapeutics, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Calixa Therapeutics, Inc., please visit www.calixainc.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.